WTA
KMTS

Washington Trust Advisors’s Kestra Medical Technologies KMTS Stock Holding History

Washington Trust Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72
Closed -$1.71K – 706
2025
Q3 		$1.71K Hold
72
– – ﹤0.01% 668
2025
Q2 		$1.19K Hold
72
– – ﹤0.01% 621
2025
Q1 		$1.79K Buy
+72
New +$1.65K ﹤0.01% 615

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Washington Trust Advisors's KMTS Position: Q4 2025 in Review

Washington Trust Advisors sold out of Kestra Medical Technologies (KMTS) in Q4 2025, closing a stake of 72 shares — an estimated $1.71K sold.

Washington Trust Advisors first reported a position in KMTS in Q1 2025 and held it in 3 quarters. The position peaked at $1.79K in Q1 2025. 107 funds tracked by Wall St. Rank hold KMTS as of Q4 2025.

  • Washington Trust Advisors reported no remaining Kestra Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 72 Kestra Medical Technologies shares in Q4 2025, an estimated $1.71K.
  • Washington Trust Advisors first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 3 quarters.
  • Washington Trust Advisors's Kestra Medical Technologies position peaked at $1.79K in Q1 2025.
  • 107 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.